Literature DB >> 20369026

RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Shimin Liu1, Gehua Zhen, Bruno P Meloni, Kym Campbell, H Richard Winn.   

Abstract

Translational stroke research is a challenging task that needs long term team work of the stroke research community. Highly reproducible stroke models with excellent outcome consistence are essential for obtaining useful data from preclinical stroke trials as well as for improving inter-lab comparability. However, our review of literature shows that the infarct variation coefficient of commonly performed stroke models ranges from 5% to 200%. An overall improvement of the commonly used stroke models will further improve the quality for experimental stroke research as well as inter-lab comparability. Many factors play a significant role in causing outcome variation; however, they have not yet been adequately addressed in the Stroke Therapy Academic Industry Roundtable (STAIR) recommendations and the Good Laboratory Practice (GLP). These critical factors include selection of anesthetics, maintenance of animal physiological environment, stroke outcome observation, and model specific factors that affect success rate and variation. The authors have reviewed these major factors that have been reported to influence stroke model outcome, herewith, provide the first edition of stroke model guidelines so to initiate active discussion on this topic. We hope to reach a general agreement among stroke researchers in the near future with its successive updated versions.

Entities:  

Year:  2009        PMID: 20369026      PMCID: PMC2848489          DOI: 10.6030/1939-067x-2.2.2

Source DB:  PubMed          Journal:  J Exp Stroke Transl Med        ISSN: 1939-067X


  206 in total

1.  C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia.

Authors:  G Yang; K Kitagawa; K Matsushita; T Mabuchi; Y Yagita; T Yanagihara; M Matsumoto
Journal:  Brain Res       Date:  1997-03-28       Impact factor: 3.252

2.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

Authors:  L Belayev; O F Alonso; R Busto; W Zhao; M D Ginsberg
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

Review 3.  A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.

Authors:  Sean I Savitz
Journal:  Exp Neurol       Date:  2007-03-12       Impact factor: 5.330

4.  Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.

Authors:  Marc Fisher; Gregory W Albers; Geoffrey A Donnan; Anthony J Furlan; James C Grotta; Chelsea S Kidwell; Ralph L Sacco; Lawrence R Wechsler
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

5.  A new model of embolic stroke produced by photochemical injury to the carotid artery in the rat.

Authors:  N Futrell; B D Watson; W D Dietrich; R Prado; C Millikan; M D Ginsberg
Journal:  Ann Neurol       Date:  1988-03       Impact factor: 10.422

6.  Microvascular basal lamina damage in thromboembolic stroke in a rat model.

Authors:  Milan R Vosko; Elmar Busch; Dorothe Burggraf; Gundula Bültemeier; Gerhard F Hamann
Journal:  Neurosci Lett       Date:  2003-12-26       Impact factor: 3.046

7.  Effects of hyperthermia on infarct volume in focal embolic model of cerebral ischemia in rats.

Authors:  Raza Noor; Chen Xu Wang; Ashfaq Shuaib
Journal:  Neurosci Lett       Date:  2003-10-02       Impact factor: 3.046

8.  Hyperbaric oxygen therapy accelerates neurologic recovery after 15-minute complete global cerebral ischemia in dogs.

Authors:  M Takahashi; N Iwatsuki; K Ono; T Tajima; M Akama; Y Koga
Journal:  Crit Care Med       Date:  1992-11       Impact factor: 7.598

9.  Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.

Authors:  Mushfiquddin Khan; Manu Jatana; Chinnasamy Elango; Ajaib Singh Paintlia; Avtar K Singh; Inderjit Singh
Journal:  Nitric Oxide       Date:  2006-03-09       Impact factor: 4.427

10.  BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.

Authors:  M J Leach; J H Swan; D Eisenthal; M Dopson; M Nobbs
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

View more
  63 in total

1.  Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response.

Authors:  Gisele Hansel; André Comiran Tonon; Felipe Lhywinskh Guella; Letícia Ferreira Pettenuzzo; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Jean Pierre Oses; Matilde Achaval; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

2.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

3.  Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.

Authors:  Mickaël Bobot; Laurent Thomas; Anaïs Moyon; Samantha Fernandez; Nathalie McKay; Laure Balasse; Philippe Garrigue; Pauline Brige; Sophie Chopinet; Stéphane Poitevin; Claire Cérini; Philippe Brunet; Françoise Dignat-George; Stéphane Burtey; Benjamin Guillet; Guillaume Hache
Journal:  J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 10.121

4.  Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area.

Authors:  Luc Bertrand; Levi Dygert; Michal Toborek
Journal:  J Vis Exp       Date:  2017-02-02       Impact factor: 1.355

Review 5.  Experimental approaches to study functional recovery following cerebral ischemia.

Authors:  Anu Lipsanen; Jukka Jolkkonen
Journal:  Cell Mol Life Sci       Date:  2011-05-29       Impact factor: 9.261

6.  Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study.

Authors:  Holger Langhof; William Wei Lim Chin; Susanne Wieschowski; Carole Federico; Jonathan Kimmelman; Daniel Strech
Journal:  Br J Pharmacol       Date:  2018-10-01       Impact factor: 8.739

Review 7.  A novel mouse model of thromboembolic stroke.

Authors:  Yingxin Chen; Wenbin Zhu; Wenri Zhang; Nicole Libal; Stephanie J Murphy; Halina Offner; Nabil J Alkayed
Journal:  J Neurosci Methods       Date:  2015-09-18       Impact factor: 2.390

8.  Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.

Authors:  Estelle Rousselet; Anne Létondor; Bénédicte Menn; Yann Courbebaisse; Marie-Lise Quillé; Serge Timsit
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-01       Impact factor: 6.200

9.  In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure.

Authors:  Fabien Chauveau; Samir Moucharrafie; Marlène Wiart; Jean-Christophe Brisset; Yves Berthezène; Norbert Nighoghossian; Tae-Hee Cho
Journal:  Exp Transl Stroke Med       Date:  2010-02-04

10.  Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation.

Authors:  Fumiaki Banno; Toshiyuki Kita; José A Fernández; Hiroji Yanamoto; Yuko Tashima; Koichi Kokame; John H Griffin; Toshiyuki Miyata
Journal:  Blood       Date:  2015-08-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.